OK.. first off... how did the offering go very quickly? What do you mean? Why are they reputable? You really sound like you work for the company.
why regret not buying more? It's only 1.18 right now. What are you hoping for?
after this placement they are getting up there in shares now. These companies love reverse splits to wipe out current holders and make it more attractive for future (I call them suckers..) you call them what you want.
Who are these to reputable firms that say RNXT is worth 4.00 now and way higher with approval?
is this Raj?
please advise
why regret not buying more? It's only 1.18 right now. What are you hoping for?
after this placement they are getting up there in shares now. These companies love reverse splits to wipe out current holders and make it more attractive for future (I call them suckers..) you call them what you want.
Who are these to reputable firms that say RNXT is worth 4.00 now and way higher with approval?
is this Raj?
please advise
Recent RNXT News
- RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/16/2026 09:10:26 PM
- Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 04/09/2026 02:19:11 PM
- RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:02 AM
- RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 • GlobeNewswire Inc. • 04/01/2026 06:20:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/31/2026 08:19:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:38:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:03 PM
- RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 11:00:10 AM
- RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:41 AM
- RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement • GlobeNewswire Inc. • 03/23/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:00:38 AM
- RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET • GlobeNewswire Inc. • 03/20/2026 12:30:00 PM
- RenovoRx Announces $10 Million at Market Private Placement • GlobeNewswire Inc. • 03/18/2026 12:35:18 PM
- RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum • GlobeNewswire Inc. • 02/27/2026 01:30:00 PM
- RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- RenovoRx Establishes RenovoCath® Medical Advisory Board • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 12:00:43 PM
